Pfizer expects 2026 revenue of $59.5 billion to $62.5 billion and adjusted earnings of $2.80 to $3 a share. Wall Street is ...

Commissioner Marty Makary on Monday denied recent reports suggesting plans for his agency to add a black box warning onto ...

Officials said they were considering such a move last week, but the plan was widely condemned by health experts.

Pregnant women who get the COVID-19 vaccine are less likely to have a preterm birth, University of British Columbia ...

U.S. lawsuits against Novo Nordisk and Eli Lilly alleging patients taking weight loss drugs lost some or all of their ...

Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...

“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” said Andrew Nixon, spokesperson for the U.S. Department of Health and Human ...

Paxlovid, an FDA-approved oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it as soon as possible ...

The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.